VARSITY: Vedolizumab showed superior Efficacy than that of Adalimumab in terms of clinical Remission and Mucosal Healing in Patients with moderate to severe active Ulcerative colitis

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2019年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [21] A metabolomics-driven model for early remission prediction following vedolizumab treatment in patients with moderate-to-severe active ulcerative colitis
    Jiang, Leilei
    Liu, Xiaoming
    Su, Yue
    Chen, Yujie
    Yang, Shaozhi
    Ke, Xiquan
    Yao, Kunhou
    Guo, Zhiguo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 128
  • [22] VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis
    Schreiber, Stefan
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Danese, Silvio
    Colombel, Jean-Frederic
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Sands, Bruce E.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S612 - S613
  • [23] A clinical study on the optimization of vedolizumab induction therapy for moderate to severe active Ulcerative Colitis at week 10
    Li, M.
    Xie, Y.
    Tian, F.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1346 - I1346
  • [24] Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission
    Wang, Hunter
    Fewings, Ingrid
    Bornman, Lee
    Shadbolt, Bruce
    Fadia, Mitali
    Subramaniam, Kavitha
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (05) : 494 - 500
  • [25] LOW FECAL CALPROTECTIN LEVEL PREDICTS HISTOLOGICAL HEALING AND PROLONGED CLINICAL REMISSION IN ULCERATIVE COLITIS PATIENTS WITH CLINICAL REMISSION AND MUCOSAL HEALING
    Kawashima, Kousaku
    Oshima, Naoki
    Yuki, Takafumi
    Kotani, Satoshi
    Sonoyama, Hiroki
    Oka, Akihiko
    Fukuba, Nobuhiko
    Mishima, Yoshiyuki
    Kazumori, Hideaki
    Ishikawa, Noriyoshi
    Maruyama, Riruke
    Kinoshita, Yoshikazu
    Ishihara, Shunji
    GASTROENTEROLOGY, 2020, 158 (06) : S461 - S462
  • [26] Histological remission (NANCY index) is superior to endoscopic mucosal healing in predicting relapse-free survival in patients with ulcerative colitis in clinical and endoscopic remission
    Wang, H.
    Fewings, I.
    Bornman, L.
    Shadbolt, B.
    Fadia, M.
    Subramaniam, K.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S71 - S71
  • [27] Efficacy of MMX-mesalamine monotherapy for maintenance of remission in ulcerative colitis patients after mucosal healing
    Lopez-Diaz, J.
    Ferreiro, R.
    De la Iglesia, D.
    Lorenzo, A.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S336 - S337
  • [28] Factors Predicting Bleeding Cessation, Mucosal Healing and Clinical Remission in Patients Receiving Topical Mesalamine with Active Distal Ulcerative Colitis
    Harris, M. Scott
    Lichtenstein, Gary
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S474 - S474
  • [29] Predictors of mucosal healing during induction therapy in patients with acute moderate-to-severe ulcerative colitis
    Motobayashi, Maiko
    Matsuoka, Katsuyoshi
    Takenaka, Kento
    Fujii, Toshimitsu
    Nagahori, Masakazu
    Ohtsuka, Kazuo
    Iwamoto, Fumihiko
    Tsuchiya, Kiichiro
    Negi, Mariko
    Eishi, Yoshinobu
    Watanabe, Mamoru
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (06) : 1004 - 1010
  • [30] Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Hibi, Toshifumi
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2014, 146 (01) : 85 - 95
12345